Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

526 recalls, newest first

Class I · High risk

SUPER HERBS 350 mg

Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.

Terminated Chemical / undeclared Super Herbs D-0909-2016
Class I · High risk

Rhino 7 Platinum 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared MSNV, Inc dba National Video Supply D-0671-2016
Class I · High risk

Rhino 7 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared MSNV, Inc dba National Video Supply D-0670-2016
Class III · Low risk

Fenofibric Acid Tablets 105 mg

Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

Terminated Chemical / undeclared Tribute Pharmaceuticals US Inc. NDC 13310-102-07 D-0017-2016
Class III · Low risk

Fenofibric Acid Tablets

Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

Terminated Chemical / undeclared Tribute Pharmaceuticals US Inc. NDC 13310-101-07 D-0016-2016
Class I · High risk

Rhino 7 Platinum 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared Premiere Sales Group D-0673-2016
Class I · High risk

Rhino 7 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared Premiere Sales Group D-0672-2016
Class I · High risk

Ultimate Herbal Slimcap Capsules

Marketed Without An Approved NDA/ANDA: product marketed as a dietary supplement was found to be tainted with undeclared sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug.

Terminated Chemical / undeclared Fit Firm and Fabulous D-0722-2016
Class I · High risk

Rhino 7 Platinum 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared Tf Supplements D-0772-2016
Class I · High risk

Rhino 7 3000

Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.

Terminated Chemical / undeclared Tf Supplements D-0771-2016
Class III · Low risk

ClomiPHENE CITRATE Tablets

Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

Terminated Chemical / undeclared EMD Serono, Inc. NDC 0093-0041-03 D-1813-2015
Class I · High risk

LiDa DAIDAIHUA

Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

Terminated Chemical / undeclared Blue Square Market, Inc. D-0296-2016
Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-914-01 D-1425-2015
Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-913-01 D-1424-2015
Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-912-01 D-1423-2015

Recalls by year